肿瘤体积在宫颈癌近距离治疗中的研究进展

doi:10.11904/j.issn.1002-3070.2023.01.011

Abstract

Abstract: Tumor volume has an important impact on the choice of brachytherapy method,dose to organs at risk,local control rate,and survival prognosis in cervical cancer.With the rapid development of targeted therapy and immunotherapy,targeted therapy,immunotherapy and concurrent chemotherapy combined external beam radiotherapy shows great clinical application prospects in the maximum tumor volume reduction rate before brachytherapy and realize individualized treatment.Therefore,this paper reviews and summarizes the research progress of tumor volume in brachytherapy of cervical cancer in recent years.

Key words: Cervical neoplasm, Tumor volume, Brachytherapy, Progress

CLC Number:

R737.33

LI Shuzhen, CAI Zhifu, RONG Yan, PANG Yebin, LUO Dongni, GAO Kun. Research progress of tumor volume in cervical cancer brachytherapy[J]. Journal of Practical Oncology, 2023, 37(1): 63-67.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2023.01.011

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2023/V37/I1/63

References

1 张艺艺,李奇,刘旭,等.宫颈癌患者五年生存及影响因素分析[J].实用肿瘤学杂志,2022,36(1):7-13.
2 刘龑昊,王俊杰.复发宫颈癌近距离治疗进展[J].中华放射肿瘤学杂志,2021,30(3):297-300.
3 Mayr NA,Taoka T,Yuh WT,et al.Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging[J].Int J Radiat Oncol Biol Phys,2002,52(1):14-22.
4 Lee KC,Kim HJ,Sung K,et al.The predictive value of tumor size,volume,and markers during radiation therapy in patients with cervical Cancer[J].Int J Gynecol Cancer,2017,27(1):123-130.
5 Chen W,Xiu S,Xie X,et al.Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer[J].Radiat Oncol,2022,17(1):6.
6 Van DL,De RM,Storme GA.Imaging in radiotherapy[J].Eur J Radiol,2000,36(1):41-48.
7 李文彬,李明华,崔雪娥,等.MRI的ROI体积测量法和直径体积测量法对宫颈癌放疗效果的临床实用性评价[J].实用放射学杂志,2004,20(7):629-632.
8 鲁玥玥,孙洪赞,马全美,等.宫颈癌¹⁸F-FDG PET与MR体积测量一致性探讨的PET/MR研究[J].中国临床医学影像杂志,2018,29(2):112-117.
9 Kruser TJ,Bradley KA,Bentzen SM,et al.The impact of hybrid PET-CT scan on overall oncologic management,with a focus on radiotherapy planning:a prospective,blinded study[J].Technol Cancer Res Treat,2009,8(2):149-158.
10 万虹,王胜军,马福成.宫颈癌¹⁸F-FDG PET/CT、增强CT及病理体积的对比研究[J].中国临床研究,2014,27(1):13-15.
11 江萍,张福泉,程光惠,等.复发宫颈癌近距离治疗专家共识[J].中华放射肿瘤学杂志,2020,29(9):721-729.
12 Marchiolé P,Buénerd A,Benchaib M,et al.Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer:a retrospective case-control surgico-pathological study[J].Gynecol Oncol,2005,97(3):727-732.
13 许雨虹,陈传本.调强放疗时代原发肿瘤体积对鼻咽癌预后的影响[J].中国医药科学,2020,10(20):195-198.
14 刘叶红,郭旗,田野.宫颈癌腹主动脉旁淋巴引流区预防性放疗的研究现状[J].中华放射肿瘤学杂志,2019,28(2):146-150.
15 Windschall A,Ott OJ,Sauer R,et al.Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma[J].Strahlenther Onkol,2005,181(8):545-550.
16 Lee JH,Lee SW,Kim JR,et al.Tumour size,volume,and marker expression during radiation therapy can predict survival of cervical cancer patients:a multi-institutional retrospective analysis of KROG 16-01[J].Gynecol Oncol,2017,147(3):577-584.
17 Tewari KS,Monk BJ.Evidence-based treatment paradigms for management of invasive cervical carcinoma[J].J Clin Oncol,2019,37(27):2472-2489.
18 Murakami N,Ando K,Murata M,et al.Why not de-intensification for uterine cervical cancer?[J].Gynecol Oncol,2021,163(1):105-109.
19 Yoshida K,Yamazaki H,Kotsuma T,et al.Simulation analysis of optimized brachytherapy for uterine cervical cancer:Can we select the best brachytherapy modality depending on tumor size?[J].Brachytherapy,2016,15(1):57-64.
20 张宁,赵志鹏,程光惠,等.局部晚期宫颈癌腔内联合组织间插植3D-IGBT的剂量学研究[J].中华放射肿瘤学杂志,2015,24(3):267-270.
21 陈俊安,刘文君,罗然,等.宫颈癌近距离放疗应用进展[J].现代肿瘤医学,2022,30(8):1512-1516.
22 修雨婷,孟凡旭,王琢,等.后装腔内联合组织间插植在ⅢB期宫颈癌中剂量学及疗效分析[J].中华放射肿瘤学杂志,2022,31(6):539-543.
23 Isohashi F,Mabuchi S,Akino Y,et al.Dose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy[J].J Radiat Res,2016,57(6):668-676.
24 Kirchheiner K,Pötter R,Tanderup K,et al.Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy:an analysis from the EMBRACE study[J].Int J Radiat Oncol Biol Phys,2016,94(5):1088-1098.
25 孙畅,路顺,张菡奕,等.肿瘤体积及瘤体缩减率在同步放化疗的宫颈癌患者预后中的价值[J].肿瘤预防与治疗,2019,32(5):421-428.
26 赵志鹏,管薇,赵红福,等.3D打印模板辅助标准化施源器在ⅢB期宫颈癌影像引导自适应近距离治疗中的应用[J].中华放射肿瘤学杂志,2020,29(8):661-665.
27 Zhang N,Tang Y,Guo X,et al.Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer:a single-center retrospective study[J].Brachytherapy,2020,19(2):194-200.
28 路顺,范子煊,孙畅,等.IMRT同步剂量补偿高剂量率后装治疗大体积宫颈癌的疗效分析[J].中华放射肿瘤学杂志,2019,28(7):522-526.
29 Yang H,Zhang Y,Liu C,et al.The integration of bevacizumab improves tumor response and survival in patients with refractory cervical cancer treated with radical chemoradiotherapy[J].Ann Transl Med,2021,9(14):1184.
30 杨华,魏丽春,张莹,等.联合贝伐珠单抗新辅助化疗＋同步放化疗治疗局部晚期巨块型宫颈癌的初步临床研究[J].中华放射肿瘤学杂志,2021,30(4):372-375.
31 高颜凤,温坚,庄茜茹.贝伐珠单抗联合同步放化疗治疗局部晚期宫颈癌的效果观察[J].中国肿瘤临床与康复,2022,29(6):713-716.
32 Mauricio D,Zeybek B,Tymon-Rosario J,et al.Immunotherapy in cervical cancer[J].Curr Oncol Rep,2021,23(6):61.
33 Lan C,Shen J,Wang Y,et al.Camrelizumab plus apatinib in patients with advanced cervical cancer(CLAP):a multicenter,open-label,single-arm,phase II trial[J].J Clin Oncol,2020,38(34):4095-4106.
34 王娟,陈大卫,于金明.放射远隔效应的量变到质变-布拉格治疗[J].中华肿瘤防治杂志,2022,29(18):1314-1316.

[1]	WU Ruiyue, ZHU Kaili, YANG Jingru, LING Xiaoling. Clinical research progress of breast cancer with low HER2 expression [J]. Journal of Practical Oncology, 2022, 36(6): 570-575.
[2]	CHEN Junhui, LIU Siyu, HE Changjun. Research progress of RUNX1 in lung cancer [J]. Journal of Practical Oncology, 2022, 36(6): 576-579.
[3]	ZHANG Yiyi, LI Qi, LIU Xu, WANG Yanan, ZOU Yuanjie, ZHOU Huihui, XU Chunyan, SU Shengqi, GE Xin, WANG Tong. Analysis of 5-year survival and its influencing factors of patients with cervical cancer [J]. Journal of Practical Oncology, 2022, 36(1): 7-13.
[4]	ZHAO Xuan, LI Guodong, LIU Ming. Research progress of metallothionein in colorectal cancer [J]. Journal of Practical Oncology, 2021, 35(6): 538-541.
[5]	ZHAO Haoran, LI Man, ZHANG Yubao. Research progress of hepatocellular carcinoma-related RNA binding protein [J]. Journal of Practical Oncology, 2021, 35(6): 576-579.
[6]	HU Hai, LI Jie, WANG Pei, TANG Bin, WANG Xianliang, YANG Qiang. Automatic applicator segmentation based on U-net model in the brachytherapy of cervical cancer [J]. Journal of Practical Oncology, 2021, 35(3): 248-253.
[7]	HU Yang, ZHANG Qingyuan. Research progress of PARP inhibitors in the treatment of BRCA1/2 mutation metastatic breast cancer [J]. Journal of Practical Oncology, 2021, 35(2): 184-187.
[8]	GUO Yongdong, JIN Jing, LI Limin, HE Yutong. Progress in differentiation of non-protein-encoding RNA(DANCR)in common malignant tumors [J]. Journal of Practical Oncology, 2020, 34(1): 69-73.
[9]	LI Guozheng, PANG Da. Progression in the treatment of HER2-positive breast cancer [J]. Journal of Practical Oncology, 2020, 34(1): 74-78.
[10]	BAO Le, TANG Liping. Progress of the EphB6 receptor in malignant tumors [J]. Journal of Practical Oncology, 2020, 34(1): 83-87.
[11]	LI Susu, ZHOU Chunxiang. Two-way regulation of NKT cells on immune response to liver cancer [J]. Journal of Practical Oncology, 2019, 33(6): 540-543.
[12]	LI Shan,ZHAO Chunbo,QIAO Wenbo. Progress in the application of intraoperative radiotherapy in pancreatic cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 280-283.
[13]	ZHUANG Minmin, ZHANG Yunyan. Research progress of intercellular adhesion molecule-1 in tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 82-86.
[14]	HAN Qian, LIN Lianjun, LIU Xinmin. Advances in gene expression profiling of metastases from unidentified primary tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 554-558.
[15]	JIANG Ying, LIU Baogang. Research progress of RCAN1 in malignant tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 559-563.

Research progress of tumor volume in cervical cancer brachytherapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments